BioSpace News Archive

Radiation therapy or radiotherapy has emerged the cost-effective cancer treatment modalities, and hence gaining significance in reducing the morbidity and mortality of cancer.

Artificial skin facilitates regeneration of skin in humans. It is a collagen scaffold.

Triple-negative breast cancer (TNBC) doesn’t have estrogen or progesterone receptors and also doesn’t make too much of the HER2 protein.

Todos Medical, Ltd. released the Nasdaq MarketSite interview between Moneta Advisory Group’s Managing Partner Marc LoPresti and CEO Gerald Commissiong, discussing the impact of Long COVID on the economy and how SARS-CoV-2 viral persistence is damaging population-level immunity leading to the rise of viral outbreaks such as MonkeyPox.

By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system.

Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines, announced that it will webcast its presentations at two investor conferences in September.

Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted ten new employees options to purchase a total of 33,950 shares of the Company’s common stock at an exercise price per share of $25.70, which was the closing price on September 8, 2022, and restricted stock units to acquire a total of 16,975 shares of the Company’s common stock.